EGRX - eagleus.com Operating profit EBITDA

Brandmark of Eagle Pharmaceuticals, Inc. (EGRX)

Packaging line automation and the digitalization of accounting are enhancing the efficiency of Eagle Pharmaceuticals (EGRX), as evidenced by GURU.Markets quotes forming this chart of absolute EBITDA, where the indicator level stands at . However, geopolitical disruptions in raw material supplies and patent theft risks create threats. Simultaneously, the company is fighting the expansion of cheap generics to protect its market share.

Eagle Pharmaceuticals (EGRX) - Operating profit EBITDA from 07/04/2022 to 11/14/2026

Summary analytical data breakdowns for Eagle Pharmaceuticals, Inc. (EGRX)

- current quotes and average value forecast:
Stock Quotes Eagle Pharmaceuticals Inc.|EGRX - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Eagle Pharmaceuticals|EGRX - Total Company Value
- book value of equity indicators:
Equity per Share Eagle Pharmaceuticals|EGRX - Book Capitalization|Market Cap to Net Assets Ratio eagleus.com|EGRX - Company Total Assets
- debt level and financial liquidity data:
Debt to Capital Eagle Pharmaceuticals|EGRX - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Eagle Pharmaceuticals Inc.|EGRX - Company Aggregate Debts|Debts to Book Value Eagle Pharmaceuticals|EGRX - Company Long-Term Debts|Company Short-Term Debts Eagle Pharmaceuticals|Critical Liquidity eagleus.com
- earnings and valuation multiples indicators:
EGRX - Company Net Income|Expected Profit Eagle Pharmaceuticals|EGRX - P/E Multiple|Projected Price to Earnings Ratio Eagle Pharmaceuticals Inc.|EGRX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Eagle Pharmaceuticals|EGRX - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Eagle Pharmaceuticals|EGRX - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months eagleus.com|EGRX - Earnings growth in current year|Earnings growth forecast for next year Eagle Pharmaceuticals
- sales revenue and business income indicators:
EGRX - Company Revenue|Company Future Revenue Eagle Pharmaceuticals Inc.|EGRX - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Eagle Pharmaceuticals
Summary company analytics:Eagle Pharmaceuticals
Manufactured product of Eagle Pharma

This indicator measures the average daily cash inflow from core operations before depreciation and interest, allowing for an assessment of the business's actual ability to generate cash amid high borrowing costs. An analysis of operating income before taxes and depreciation confirms the resilience of Eagle Pharmaceuticals (EGRX), whose proprietary oncology drugs ensure stable margins and a predictable free cash flow.

Who Eagle Pharmaceuticals competes with

OLMA - Operating profit before deduction of amortization|Puma Biotechnology Inc - Operating profit EBITDA|GLSI - Operating profit EBITDA|Zentalis (ZNTL) - Profit before payment of interest, taxes and amortization|Operating profit before amortization MGNX|PSTV (Plus Therapeutics Inc) - Operating profit EBITDA|Operating profit before deduction of amortization Processa Pharma (PCSA)